Nexus Life Science Partners Mergers & Acquisitions

Nexus Life Science Partners M&A Summary

The Firm’s most common exit type is trade sale (46%). Nexus Life Science Partners’ largest (disclosed) exit occurred in 2005 when it sold Abgenix for $2.2B.

Sign-up to view Nexus Life Science Partners’ full profile and discover more small growth capital firm investors just like it.

M&A Summary

  • M&A Total Activity29
    • M&A Buy Activity7
    • M&A Sell Activity22
  • M&A Buy/Sell Connections14

Nexus Life Science Partners

424 West, 33rd Street, Suite 520,
New York, New York 10001
United States
www.merlinnexus.com
invest@merlinnexus.com

All (29) Buy (7) Sell (22)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2020-11-30 Sunesis · Life Science
South San Francisco, California · www.sunesis.com

Sunesis is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics for oncology and other serious diseases. Sunesis was founded in 1998 and is based in South San Francisco, California.

Advisors: Cooley , MTS Health Partners
- Merger

Viracta Therapeutics
Advisors: Evercore Group , Wilson Sonsini Goodrich & Rosati

Alta Partners PE

Bay City Capital PE

Nexus Life Science Partners PE


Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.